维普期刊资源整合服务平台（V6.5）

1954篇 您的检索式：期刊名="Proc AM Clin"

选中清除导出查看参考文献查看引证文献引用追踪共98页首页上一页第1页下一页末页 /98 跳转

	题名	作者	年代	出处	被引量
1	Long-term benefit is observed in a phase Ⅲ comparison of sequential vs concurrent chemoradiation for patients with unresected stage Ⅲ NSCLC: RTOG 9410显示文摘	Curran WJ Scott CB Langer CJ	2003	Proc Am Soc Clin Oncol2003，22，：	1
2	ECOG 4599 phase Ⅲ trial of carboplatin and paclitaxel ± bevacizumab: Subset analysis of survival by gender显示文摘	BRAHMER JR GRAY R SCHILLER JH	2006	Proc Am Soc Clin Oncol2006，24，：	1
3	Results of surgery for liver metastases (LM) after neoadjuvant chemotherapy (CT) with irinotecan + infusional fluorouracil/leucovorin ( Iri - FU/LV ) in patients (pts) with colorectal cancer ( CRC ) 显示文摘	Clavero - Fabri MC Mitry E Chidiac J	2003	Proc Am Soc Clin Oncol2003，22，：	1
4	Phase III randomized comparison of gemcitabine and carboplatin(GC) with mitomycin,ifosfamide and cisplatin (MIP) in advanced non - small cell lung cancer( NSCLC ) 显示文摘	Rudd RM Gower NH James LE	2002	Proc Am Soc Clin Oncol2002，21，：	1
5	Neo-adjuvant treatment with erlotinib in squamous cell carcinoma head and neck (SCCHN) patients before surgery provides an opportunity to find predictive factors of response显示文摘	Delord J Thomas F Benlyazid A	2006	Proc Am Soc Clin Oncol2006，24，：	1
6	High efficacy but considerable toxicity of campath - 1H consolidation therapy in CLL patients responding to fludarabine - results of a randomized phase Ⅲ trial显示文摘	Ritgen M Jaeger G	2003	Proc Am Soc Clin Oncol2003，22，：	1
7	CA15-3and CEA spikes during chemotherapy for metastatic breast cancer显示文摘	Hayes DF Kiang DT Korzum AH	1998	Proc Am Soc Clin Oncol1998，7，：	1
8	Randomized phase III study of 5-fluorouracil (5-FU) alone versus combination of irinotecan and cisplatin (CP) versus S-1 alone in advanced gastric cancer (JCOG9912)显示文摘	Boku N Yamamoto S Shirao K		Proc Am Soc Clin Oncol0，25，：	1
9	Letrozole, a new potent, selective aromatase inhibitor superior to aminoglutethimide (AG) in postmenopausal women with advanced breast cancer previously treated with antiestrogens显示文摘	Marty M Gershanovich M Campos B	1997	Proc AM Soc Clin Oncol1997，16，：	1
10	Overall survival advantage to simultaneous chemotherapy plus the humannized anti-HeR2 monoclonal antibody Herceptine in HER2 overexpressing metastatic breast cancer 显示文摘	Norton L Slamon D Leyland-Jones b	1999	Proc Am Soc Clin Oncol1999，18，：	1
11	Paclitaxel-cisplatin versus teniposide-cisplation in advanced non-small cell lung cancer 显示文摘	Giaccone G Splinter T Postmus P	1996	Proc Am Soc Clin Oncol1996，15，：	1
12	The proteosome inhibitor PS-341 (Bortezomib) in platinum (plat)-treated extensive stage small cell lung cancer (E-SCLC):A SWOG (0327)phase Ⅱ trial显示文摘	Johl J Chansky K Lara PN	2005	Proc Am Soc Clin Oncol2005，，：	1
13	Significance of hemoglobin changes during chemoradiotherapy in non-small cell lung cancer (NSCLC): an analysis of three sequential trials 显示文摘	MacRae R Choy K Shyr Y	2001	Proc Am Soc Clin Oncol2001，20，：	1
14	Adjuvant chemohormonal therapy for primary breast cancer should be sequential instead of concurrent:initial results from intergroup trial 0100 (SWOG-8814)显示文摘	Albain KS Green S J Ravdin PM	2002	Proc Am Soc Clin Oncol2002，21，：	1
15	A randomized phase Ⅲ study of concurrent vs sequential thoracic radiotherapy in combination with mitomycia,videsine and cisplatin in unresected stage Ⅲ non-small-cell lung cancer:Preliminary analysis(abstract)显示文摘	Furuse K Fukuoka M Takada Y	1997	Proc Am Soc Clin Oncol1997，16，：	1
16	Phase I study of anti-epidermal growth factor receptor antibody c225 in combination with irradiation in patients with advanced squamous cell carcinoma of the head and neck显示文摘	Ezekiel MP Robert F Meredith RF	1998	Proc Am Soc Clin Oncol1998，17，：	1
17	Randomized phase Ⅲ trial of sorafenib in advanced renal cell carcinoma (RCC):Impact of crossover on survival (abst) 显示文摘	Eisen T Bukowski RM Staehler M	2006	Proc Am Soc Clin Oncol2006，24，：	1
18	Gefitinib (ZD1839) therapy for advanced brochioalverlar lung cancer (BAC) : Southwest Oncology Group (SWOG) Study S0126显示文摘	West H Franklin WA Gumerlock PH	2004	Proc Am Soc Clin Oncol2004，23，：	1
19	Capecitabine plus OXALIPLATIN (XELOX): highly active , fine combination therapy for metastatic CRC 显示文摘	Tabernero J	2002	Proc Am Soc Clin Oncol2002，21，：	1
20	Efficacy, tolerability and pharma- cokinetics of gefitinib ( ZD1839 ) in pretreated patients with meta- static gastric cancer显示文摘	Doi T Koizumi W Siena S	2005	Proc Am Soc Clin Oncol2005，，22：	1

返回顶部每页显示：

共98页首页上一页第1页下一页末页 /98 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示